Logo image of SRG

SERITAGE GROWTH PROP- A (SRG) Stock Fundamental Analysis

NYSE:SRG - US81752R1005 - Common Stock

3.74 USD
+0.07 (+1.91%)
Last: 9/5/2025, 8:04:00 PM
Fundamental Rating

1

SRG gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 63 industry peers in the Real Estate Management & Development industry. The financial health of SRG is average, but there are quite some concerns on its profitability. SRG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SRG has reported negative net income.
In the past year SRG has reported a negative cash flow from operations.
SRG had negative earnings in each of the past 5 years.
In the past 5 years SRG always reported negative operating cash flow.
SRG Yearly Net Income VS EBIT VS OCF VS FCFSRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

SRG has a worse Return On Assets (-15.45%) than 73.02% of its industry peers.
SRG's Return On Equity of -25.31% is on the low side compared to the rest of the industry. SRG is outperformed by 63.49% of its industry peers.
Industry RankSector Rank
ROA -15.45%
ROE -25.31%
ROIC N/A
ROA(3y)-14.69%
ROA(5y)-9.92%
ROE(3y)-26.18%
ROE(5y)-20.06%
ROIC(3y)N/A
ROIC(5y)N/A
SRG Yearly ROA, ROE, ROICSRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SRG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SRG Yearly Profit, Operating, Gross MarginsSRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

SRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
SRG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, SRG has more shares outstanding
Compared to 1 year ago, SRG has an improved debt to assets ratio.
SRG Yearly Shares OutstandingSRG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SRG Yearly Total Debt VS Total AssetsSRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

SRG has an Altman-Z score of -2.05. This is a bad value and indicates that SRG is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.05, SRG is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.57 indicates that SRG is somewhat dependend on debt financing.
SRG has a Debt to Equity ratio of 0.57. This is comparable to the rest of the industry: SRG outperforms 50.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -2.05
ROIC/WACCN/A
WACC10.14%
SRG Yearly LT Debt VS Equity VS FCFSRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

SRG has a Current Ratio of 3.60. This indicates that SRG is financially healthy and has no problem in meeting its short term obligations.
SRG has a Current ratio of 3.60. This is amongst the best in the industry. SRG outperforms 80.95% of its industry peers.
SRG has a Quick Ratio of 3.60. This indicates that SRG is financially healthy and has no problem in meeting its short term obligations.
SRG has a Quick ratio of 3.60. This is amongst the best in the industry. SRG outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 3.6
Quick Ratio 3.6
SRG Yearly Current Assets VS Current LiabilitesSRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 27.41% over the past year.
SRG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.25%.
SRG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -36.34% yearly.
EPS 1Y (TTM)27.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.01%
Revenue 1Y (TTM)-30.25%
Revenue growth 3Y-46.75%
Revenue growth 5Y-36.34%
Sales Q2Q%10.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SRG Yearly Revenue VS EstimatesSRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SRG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRG Price Earnings VS Forward Price EarningsSRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SRG Per share dataSRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SERITAGE GROWTH PROP- A

NYSE:SRG (9/5/2025, 8:04:00 PM)

3.74

+0.07 (+1.91%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)08-12 2025-08-12
Earnings (Next)11-10 2025-11-10
Inst Owners47.31%
Inst Owner Change-0.86%
Ins Owners13.09%
Ins Owner Change-0.26%
Market Cap210.64M
Analysts80
Price Target6.63 (77.27%)
Short Float %17.4%
Short Ratio48.95
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.09
Dividend Growth(5Y)-32.24%
DP-5.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-23.53%
PT rev (3m)-23.53%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 12.47
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.6
EV/EBITDA N/A
EPS(TTM)-1.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.9
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS0.3
BVpS6.24
TBVpS6.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.45%
ROE -25.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-14.69%
ROA(5y)-9.92%
ROE(3y)-26.18%
ROE(5y)-20.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.6
Quick Ratio 3.6
Altman-Z -2.05
F-Score4
WACC10.14%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%71.01%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.25%
Revenue growth 3Y-46.75%
Revenue growth 5Y-36.34%
Sales Q2Q%10.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.19%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.65%
OCF growth 3YN/A
OCF growth 5YN/A